FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for HUMALOG KWIKPEN (insulin lispro) submitted by Eli Lilly, resulting in a labeling action for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• HUMALOG KWIKPEN (insulin lispro)

Snippet

SUPPL AP for HUMALOG KWIKPEN (INSULIN LISPRO)